During the past decade, Ospedale San Paolo ASL 2 Savonese conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Paolo ASL 2 Savonese" #1 collaborator was "Agenzia Italiana del Farmaco" with 2 trials as a collaborator and "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Paolo ASL 2 Savonese" are "COVID-19" (2 trials). Many other conditions were trialed in "Ospedale San Paolo ASL 2 Savonese" in a lesser frequency.

Most popular intervention types in "Ospedale San Paolo ASL 2 Savonese" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sotrovimab" (2 trials), "Bamlanivimab Etesevimab" (1 trials), "Casirivimab-Imdevimab" (1 trials), "Nirmatrelvir Ritonavir" (1 trials) and "Tixagevimab Cilgavimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Paolo ASL 2 Savonese" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale San Paolo ASL 2 Savonese". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospedale San Paolo ASL 2 Savonese, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Paolo ASL 2 Savonese, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".